Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1508 Articles

Chris Lange | Feb 10, 2017 at 8:35 AM EST

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far…

Chris Lange | Jan 31, 2017 at 8:55 AM EST

Are Pfizer’s Acquisitions Holding Back Its Bottom Line?

When Pfizer reported its fourth-quarter financial results before the markets opened on Tuesday, earnings fell short of consensus estimates.

Chris Lange | Jan 30, 2017 at 11:45 AM EST

Top 7 Earnings Reports to Look For Tuesday

24/7 Wall St. has put together a preview of some of the major companies reporting on Tuesday, including Apple and…

Chris Lange | Jan 29, 2017 at 10:25 AM EST

What to Expect From Dow Stocks Reporting This Week

Five of the Dow stocks are reporting next week, and this has the potential to sustain the run that the…

Chris Lange | Jan 26, 2017 at 9:50 AM EST

Short Sellers Run for Cover From Major Pharma

The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Paul Ausick | Jan 20, 2017 at 11:25 AM EST

5 Worst Performing Dow Stocks of 2017

Even though the new year is barely three weeks old, it's not too soon to take a look at how…

Paul Ausick | Jan 19, 2017 at 4:01 PM EST

Exxon Mobil, Merck Weigh on DJIA Thursday

Exxon Mobil, Merck, Goldman Sachs, and Pfizer sink the DJIA on Thursday.

Paul Ausick | Jan 17, 2017 at 4:01 PM EST

JPMorgan, Goldman Sachs Sink DJIA on Tuesday

JPMorgan, Goldman Sachs, Pfizer, and UnitedHealth sink DJIA on Tuesday.

Paul Ausick | Jan 12, 2017 at 4:01 PM EST

Disney, Microsoft Lead DJIA Drop Thursday

Disney, Microsoft, Pfizer, and Intel lead DJIA to lower close on Thursday.

Chris Lange | Jan 12, 2017 at 10:50 AM EST

Major Pharma Short Interest Declines Ahead of Trump Comments

The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a…

Chris Lange | Jan 11, 2017 at 3:22 PM EST

Wednesday’s Top Biopharma Movers

Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the…

Chris Lange | Jan 5, 2017 at 11:05 AM EST

2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth

Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a…

Jon C. Ogg | Dec 31, 2016 at 11:14 AM EST

Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside

One strategy that has been quite common as investors rebalance and make changes each year is the Dogs of the…

Jon C. Ogg | Dec 29, 2016 at 10:30 AM EST

Beyond DJIA 20,000: What Could Drive the Dow to 22,000 in 2017

The Dow has been within 1% of 20,000 for days now. What if the Dow actually manages to hit 22,000…

Douglas A. McIntyre | Dec 29, 2016 at 7:35 AM EST

5 Companies That Will Kill the Dow’s Move to 20,000

Most of the 30 components of the Dow Jones Industrial Average have risen by double-digit percentages this year. But these…

1 … 44 45 46 47 48 … 101

Pfizer : PFE

All Pfizer Articles

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

Are Pfizer’s Acquisitions Holding Back Its Bottom Line?

Top 7 Earnings Reports to Look For Tuesday

What to Expect From Dow Stocks Reporting This Week

Short Sellers Run for Cover From Major Pharma

5 Worst Performing Dow Stocks of 2017

Exxon Mobil, Merck Weigh on DJIA Thursday

JPMorgan, Goldman Sachs Sink DJIA on Tuesday

Disney, Microsoft Lead DJIA Drop Thursday

Major Pharma Short Interest Declines Ahead of Trump Comments

Wednesday’s Top Biopharma Movers

2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth

Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside

Beyond DJIA 20,000: What Could Drive the Dow to 22,000 in 2017

5 Companies That Will Kill the Dow’s Move to 20,000

Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

Jim Cramer Says Google Could Win the Entire AI War: The 2.5 Billion Apple Devices Behind It Are Why

Analyst Reveals How $200 Billion in Leveraged ETFs Could Amplify the Next Market Selloff

$2,500 a Month in The Villages: Here’s How to Retire There at 62 Without Touching Your Savings

$2,500 a Month in The Villages: Here's How to Retire There at 62 Without Touching Your Savings

BofA Consumer Chief: Spending Jumps 6.3% With Wage Growth Across “All Income Groups”

Billionaire Tech CEO: Our $25 Billion Backlog Shows “The Demand Is Booked” as “We’ve Never Seen a Buildout Like This Since the Great Wall of China”

Jim Cramer Says Google Could Win the Entire AI War: The 2.5 Billion Apple Devices Behind It Are Why

Pfizer : PFE

All Pfizer Articles

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

Are Pfizer’s Acquisitions Holding Back Its Bottom Line?

Top 7 Earnings Reports to Look For Tuesday

What to Expect From Dow Stocks Reporting This Week

Short Sellers Run for Cover From Major Pharma

5 Worst Performing Dow Stocks of 2017

Exxon Mobil, Merck Weigh on DJIA Thursday

JPMorgan, Goldman Sachs Sink DJIA on Tuesday

Disney, Microsoft Lead DJIA Drop Thursday

Major Pharma Short Interest Declines Ahead of Trump Comments

Wednesday’s Top Biopharma Movers

2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth

Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside

Beyond DJIA 20,000: What Could Drive the Dow to 22,000 in 2017

5 Companies That Will Kill the Dow’s Move to 20,000

Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

Jim Cramer Says Google Could Win the Entire AI War: The 2.5 Billion Apple Devices Behind It Are Why

Analyst Reveals How $200 Billion in Leveraged ETFs Could Amplify the Next Market Selloff

$2,500 a Month in The Villages: Here’s How to Retire There at 62 Without Touching Your Savings

Featured Reads

$2,500 a Month in The Villages: Here's How to Retire There at 62 Without Touching Your Savings

BofA Consumer Chief: Spending Jumps 6.3% With Wage Growth Across “All Income Groups”